Southern Research is a leading contract research organization (CRO) that specializes in the preclinical development of recombinant protein-based vaccines. We have a team of experienced scientists and researchers who are experts in all aspects of recombinant protein-based vaccine development, including:
- Design, construction, expression, and purification of recombinant protein-based vaccine candidates
- Adjuvant selection, formulation, and stability testing for recombinant protein-based vaccine candidates
- In vitro and in vivo testing of recombinant protein-based vaccine candidates
- Assessment of the safety and efficacy of recombinant protein-based vaccine candidates in animal models
- Assistance and consulting on the development and scale-up of a manufacturing process for recombinant protein-based vaccine candidates
We offer a wide range of preclinical recombinant protein-based vaccine development services, including:
-
- Feasibility studies: We can help you assess the feasibility of developing a recombinant protein-based vaccine for your target disease.
- Lead optimization: We can help you optimize your recombinant protein-based vaccine candidate to improve its safety and efficacy.
- Preclinical testing: We can conduct all of the necessary preclinical testing to evaluate thesafety and efficacy of your recombinant protein-based vaccine candidate in animal models.
- Manufacturing development: We can help you develop a manufacturing process for yourrecombinant protein-based vaccine candidate so that it can be produced at scale for clinical trials.
If you are developing a recombinant protein-based vaccine candidate, we encourage you to contact us to learn more about how we can help you accelerate your vaccine development.
